Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metforminin Subjects With ...